Top Markets
Coin of the day
Berry Genomics Co.,Ltd Berry Genomics Co.,Ltd

Berry Genomics Co.,Ltd

000710
Clasificación en acciones #13832
Berry Genomics Co.,Ltd, a genomics and life science company, develops and... Berry Genomics Co.,Ltd, a genomics and life science company, develops and commercializes of genetic test technologies in clinical applications in China. The company offers non-invasive DNA prenatal testing service, genetic disease testing, tumor genetic testing, NextSeq CN500 gene sequencer, and laboratory solutions. It also provides technology services, such as human genome sequencing, transcriptional regulation, single cell/spatial sequencing, animal and plant genome resequencing, genome denovo sequencing, and microbial sequencing, as well as big data services. The company serves various organizations and facilities, including hospitals, research institutions, universities, and enterprises throughout Mainland China, Hong Kong, Macao, Taiwan, Southeast Asia, the Middle East, and Australia. The company was founded in 2010 and is headquartered in Beijing, China.
Precio por acción
$1.29
Capitalización bursátil
$456.97M
Cambio (1 día)
-1.22%
Cambio (1 año)
-38.75%
País
CN
Comercio Berry Genomics Co.,Ltd (000710)

Categoría

Ganancias de Berry Genomics Co.,Ltd (000710)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Berry Genomics Co.,Ltd, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Berry Genomics Co.,Ltd desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
$7.61B -
US
$4.76B -
US
- -
CN
$-252.70M -
US
$1.42B -
US